Publications
Our deep expertize of the Polish healthcare market is displayed in our research. It allows it so objectively, competently and with credibility describe the reality in many fields of healthcare.
-
Oncology patients’ access to drug therapies in Poland in view of current medical knowledgeDownload Read onlineA report prepared by PEX PharmaSequence for the Alivia Oncology Foundation financed with a grant from the Council of Employers of Poland
-
RSA in Drug Reimbursement System in Poland and AbroadDownload Read onlineExecutive summary of a report prepared by Sequence, HTA Consulting and Ryś & Associates Law Firm. The publication deals with the use of risk sharing agreements in introduction of new drugs to the reimbursement system.
-
Patient's price acceptanceDownload Read onlineExcerpt from a report on growth opportunities that PEX PharmaSequence delivered for a major international drug manufacturer
